Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
La safinamida, cuyo nombre químico es (S) -2- [4- (3-fluorobenciloxi) bencilamino] propionamida metanosulfonato, es un fármaco anti-Parkinson desarrollado por Newron Pharmaceuticals, actualmente en fase III de investigación clínica. Clínicamente se ha demostrado que este medicamento puede mejorar la función motora y cognitiva de los pacientes con enfermedad de Parkinson, prevenir la discinesia en los pacientes y tiene buena tolerancia.
PRODUCTOS POR GRUPO : Intermedios API > Intermedio de mesilato de safinamida
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.